Barbara Seliger (Chiara Massa)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 50

Top Venues

Oncoimmunology

Clinical and translational medicine

Cancers

Biomolecules

Martin-Luther-Universitat Halle-Wittenberg Medizinische Fakultat

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Martin-Luther-Universitat Halle-Wittenberg Medizinische Fakultat Dec 01 2004

Germany

Director :: Institute of medical Immunology

Publications

Yuan Wang, Barbara Seliger
Identification of RNA-binding protein hnRNP C targeting the 3'UTR of the TAP-associated glycoprotein tapasin in melanoma. Oncoimmunology 13 (1) (2024)
Yuan Wang, Barbara Seliger
Identification of RNA-binding protein hnRNP C targeting the 3'UTR of the TAP-associated glycoprotein tapasin in melanoma. Oncoimmunology 13 (1) (2024)
Christoforos K Vaxevanis, Michael Bachmann, Barbara Seliger
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy. Journal for immunotherapy of cancer 12 (8) (2024)
Christoforos K Vaxevanis, Michael Bachmann, Barbara Seliger
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy. Journal for immunotherapy of cancer 12 (8) (2024)
Barbara Seliger, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens Uwe Blohmer, Dirk-Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marmé, Jens Huober, Volkmar Müller, Christian Schem, Anja Müller, Elmar Stickeler, Katharina Biehl, Peter A Fasching, Michael Untch, Sibylle Loibl, Carsten Denkert, Barbara Seliger
Baseline CD4 + and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. Clinical and translational medicine 14 (4) (2024)
Yuan Wang, Barbara Seliger
Identification of RNA-binding protein hnRNP C targeting the 3'UTR of the TAP-associated glycoprotein tapasin in melanoma. Oncoimmunology 13 (1) (2024)
Barbara Seliger, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens Uwe Blohmer, Dirk-Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marmé, Jens Huober, Volkmar Müller, Christian Schem, Anja Müller, Elmar Stickeler, Katharina Biehl, Peter A Fasching, Michael Untch, Sibylle Loibl, Carsten Denkert, Barbara Seliger
Baseline CD4 + and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. Clinical and translational medicine 14 (4) (2024)
Barbara Seliger, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens Uwe Blohmer, Dirk-Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marmé, Jens Huober, Volkmar Müller, Christian Schem, Anja Müller, Elmar Stickeler, Katharina Biehl, Peter A Fasching, Michael Untch, Sibylle Loibl, Carsten Denkert, Barbara Seliger
Baseline CD4 + and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients. Clinical and translational medicine 14 (4) (2024)
Lamiaa Hassan, Ahmed Bedir, Frank Bernhard Kraus, Christian Ostheimer, Dirk Vordermark, Rafael T Mikolajczyk, Barbara Seliger, Daniel Medenwald
Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study. Cancers 16 (3) (2024)
Lamiaa Hassan, Ahmed Bedir, Frank Bernhard Kraus, Christian Ostheimer, Dirk Vordermark, Rafael T Mikolajczyk, Barbara Seliger, Daniel Medenwald
Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study. Cancers 16 (3) (2024)
Rocmira Perez-Nicado, Chiara Massa, Laura Marta Rodríguez-Noda, Anja Müller, Rinaldo Puga-Gómez, Yariset Ricardo-Delgado, Beatriz Paredes-Moreno, Meiby Rodríguez-González, Marylé García-Ferrer, Ilianet Palmero-Álvarez, Aniurka Garcés-Hechavarría, Daniel G Rivera, Yury Valdés-Balbín, Vicente Verez Bencomo, Dagmar García-Rivera, Barbara Seliger
Comparative Immune Response after Vaccination with SOBERANA ® 02 and SOBERANA ® plus Heterologous Scheme and Natural Infection in Young Children. Vaccines 11 (11) (2023)
Miriam Moeller, Wolfgang Schütte, Steffi Turzer, Barbara Seliger, Dagmar Riemann
Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy. Cancers 15 (19) (2023)
Dagmar Riemann, Steffi Turzer, Georgi Ganchev, Wolfgang Schütte, Barbara Seliger, Miriam Moeller
Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy. Biomolecules 13 (2) (2023)
Antonino Alejandro Pane, Theresa Kordaß, Agnes Hotz-Wagenblatt, Elke Dickes, Annette Kopp-Schneider, Rainer Will, Barbara Seliger, Wolfram Osen, Stefan B Eichmüller
MicroRNAs affecting the susceptibility of melanoma cells to CD8 + T cell-mediated cytolysis. Clinical and translational medicine 13 (2) (2023)
Antonino Alejandro Pane, Theresa Kordaß, Agnes Hotz-Wagenblatt, Elke Dickes, Annette Kopp-Schneider, Rainer Will, Barbara Seliger, Wolfram Osen, Stefan B Eichmüller
MicroRNAs affecting the susceptibility of melanoma cells to CD8 + T cell-mediated cytolysis. Clinical and translational medicine 13 (2) (2023)
Dagmar Riemann, Steffi Turzer, Georgi Ganchev, Wolfgang Schütte, Barbara Seliger, Miriam Moeller
Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy. Biomolecules 13 (2) (2023)
Dagmar Riemann, Steffi Turzer, Georgi Ganchev, Wolfgang Schütte, Barbara Seliger, Miriam Moeller
Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy. Biomolecules 13 (2) (2023)
Dagmar Riemann, Steffi Turzer, Georgi Ganchev, Wolfgang Schütte, Barbara Seliger, Miriam Moeller
Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy. Biomolecules 13 (2) (2023)
Matthias Bache, Frauke Kadler, Olivia Struck, Daniel Medenwald, Christian Ostheimer, Antje Güttler, Jacqueline Keßler, Matthias Kappler, Anne Riemann, Oliver Thews, Barbara Seliger, Dirk Vordermark
Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients. International journal of molecular sciences 24 (16) (2023)
Helene Schäfer, Karthikeyan Subbarayan, Chiara Massa, Christoforos Vaxevanis, Anja Mueller, Barbara Seliger
Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma. Journal of translational medicine 21 (1) (2023)
Chiara Massa, Yuan Wang, Nico Marr, Barbara Seliger
Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway. International journal of molecular sciences 24 (7) (2023)
Antonino Alejandro Pane, Theresa Kordaß, Agnes Hotz-Wagenblatt, Elke Dickes, Annette Kopp-Schneider, Rainer Will, Barbara Seliger, Wolfram Osen, Stefan B Eichmüller
MicroRNAs affecting the susceptibility of melanoma cells to CD8 + T cell-mediated cytolysis. Clinical and translational medicine 13 (2) (2023)
Marcus Bauer, Martina Vetter, Kathrin Stückrath, Meron Yohannes, Zelalem Desalegn, Tewodros Yalew, Yonas Bekuretsion, Tariku W Kenea, Maureen Joffe, Eunice J Van Den Berg, Julien Ilunga Nikulu, Kamaté Bakarou, Shyam S Manraj, Olufemi John Ogunbiyi, Ima-Obong Ekanem, Festus Igbinoba, Mohenou Diomande, Clement A Adebamowo, Charles P Dzamalala, Angelica A Anele, Annelle Zietsman, Moses Galukande, Milena Foerster, Isabel Dos Santos Silva, Biying Liu, Pablo S C Santos, Ahmedin Jemal, Tamrat Abebe, Claudia Wickenhauser, Barbara Seliger, Valerie A McCormack, Eva Johanna Kantelhardt
Regional variation in the tumor microenvironment, immune escape and prognostic factors in breast cancer in sub-Saharan Africa. Cancer immunology research (2023)
Antonino Alejandro Pane, Theresa Kordaß, Agnes Hotz-Wagenblatt, Elke Dickes, Annette Kopp-Schneider, Rainer Will, Barbara Seliger, Wolfram Osen, Stefan B Eichmüller
MicroRNAs affecting the susceptibility of melanoma cells to CD8 + T cell-mediated cytolysis. Clinical and translational medicine 13 (2) (2023)
Barbara Seliger, Simon Jasinski-Bergner, Chiara Massa, Anja Mueller, Katharina Biehl, Bo Yang, Michael Bachmann, Danny Jonigk, Philip Eichhorn, Arndt Hartmann, Claudia Wickenhauser, Marcus Bauer
Induction of pulmonary HLA-G expression by SARS-CoV-2 infection. Cellular and molecular life sciences : CMLS 79 (11) (2022)
Miriam Möller, Steffi Turzer, Georgi Ganchev, Andreas Wienke, Wolfgang Schütte, Barbara Seliger, Dagmar Riemann
Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade. Cancers 14 (15) (2022)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Simon Jasinski-Bergner, Juliane Blümke, Marcus Bauer, Saskia Luise Skiebe, Ofer Mandelboim, Claudia Wickenhauser, Barbara Seliger
Novel approach to identify putative Epstein-Barr-virus microRNAs regulating host cell genes with relevance in tumor biology and immunology. Oncoimmunology 11 (1) (2022)
Chiara Massa, Barbara Seliger
Enhanced function of vaccine dendritic cells from obese donors upon inhibition of the lipid metabolism. Clinical and translational medicine 12 (2) (2022)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Karthikeyan Subbarayan, Chiara Massa, Maria-Filothei Lazaridou, Kamatchi Ulagappan, Barbara Seliger
Identification of a novel miR-21-3p/TGF-β signaling-driven immune escape via the MHC class I/biglycan axis in tumor cells. Clinical and translational medicine 11 (3) (2022)
Christoforos K Vaxevanis, Marcus Bauer, Karthikeyan Subbarayan, Michael Friedrich, Chiara Massa, Katharina Biehl, Haifa Kathrin Al-Ali, Claudia Wickenhauser, Barbara Seliger
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy. Oncoimmunology 12 (1) (2022)
Alexander Stein, Donjete Simnica, Christoph Schultheiß, Rebekka Scholz, Joseph Tintelnot, Eray Gökkurt, Lisa von Wenserski, Edith Willscher, Lisa Paschold, Markus Sauer, Sylvie Lorenzen, Jorge Riera-Knorrenschild, Reinhard Depenbusch, Thomas J Ettrich, Steffen Dörfel, Salah-Eddin Al-Batran, Meinolf Karthaus, Uwe Pelzer, Lisa Waberer, Axel Hinke, Marcus Bauer, Chiara Massa, Barbara Seliger, Claudia Wickenhauser, Carsten Bokemeyer, Susanna Hegewisch-Becker, Mascha Binder
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer. Journal for immunotherapy of cancer 9 (7) (2022)
Georgiana Toma, Eliza Karapetian, Chiara Massa, Dagmar Quandt, Barbara Seliger
Characterization of the effect of histone deacetylation inhibitors on CD8 + T cells in the context of aging. Journal of translational medicine 20 (1) (2022)
Christoforos K Vaxevanis, Michael Friedrich, Sandy Uta Tretbar, Diana Handke, Yuan Wang, Juliane Blümke, Reinhard Dummer, Chiara Massa, Barbara Seliger
Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanoma. Clinical and translational medicine 12 (7) (2022)
Karthikeyan Subbarayan, Chiara Massa, Sandra Leisz, André Steven, Daniel Bethmann, Katharina Biehl, Claudia Wickenhauser, Barbara Seliger
Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells. Oncoimmunology 11 (1) (2022)
Chiara Massa, Thomas Karn, Carsten Denkert, Andreas Schneeweiss, Claus Hanusch, Jens-Uwe Blohmer, Dirk-Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marme, Jens Huober, Volkmar Müller, Christian Schem, Anja Mueller, Elmar Stickeler, Katharina Biehl, Peter A Fasching, Michael Untch, Sibylle Loibl, Karsten Weber, Barbara Seliger
Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC. Journal for immunotherapy of cancer 8 (2) (2021)
Simon Jasinski-Bergner, Juliane Blümke, Claudia Wickenhauser, Barbara Seliger
Relevance of 2'-O-Methylation and Pseudouridylation for the Malignant Melanoma. Cancers 13 (5) (2021)
Stefanie Meyer, Diana Handke, Anja Mueller, Katharina Biehl, Markus Kreuz, Jürgen Bukur, Ulrike Koehl, Maria-Filothei Lazaridou, Mark Berneburg, André Steven, Chiara Massa, Barbara Seliger
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma. Cancers 13 (15) (2021)
Philip Zeuschner, Sebastian Hölters, Michael Stöckle, Barbara Seliger, Anja Mueller, Hagen S Bachmann, Viktor Grünwald, Daniel C Christoph, Arnulf Stenzl, Marc-Oliver Grimm, Fabian Brüning, Peter J Goebell, Marinela Augustin, Frederik Roos, Johanna Harde, Iris Benz-Rüd, Michael D Staehler, Kerstin Junker
Thrombospondin-2 and LDH Are Putative Predictive Biomarkers for Treatment with Everolimus in Second-Line Metastatic Clear Cell Renal Cell Carcinoma (MARC-2 Study). Cancers 13 (11) (2021)
Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus-Peter Heußel, Felix J Herth, Hauke Winter, Michael Meister, Thomas Muley, Stefan Fröhling, Solange Peters, Barbara Seliger, Peter Schirmacher, Michael Thomas, Petros Christopoulos, Albrecht Stenzinger
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma. Oncoimmunology 10 (1) (2021)
Marcus Bauer, Simon Jasinski-Bergner, Ofer Mandelboim, Claudia Wickenhauser, Barbara Seliger
Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies. Cancers 13 (20) (2021)
Naomi C Bosch, Lena-Marie Martin, Caroline J Voskens, Carola Berking, Barbara Seliger, Gerold Schuler, Niels Schaft, Jan Dörrie
A Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells. International journal of molecular sciences 22 (19) (2021)
Maria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, Michael Friedrich, Diana Handke, Anja Mueller, Simon Jasinski-Bergner, Reinhard Dummer, Peter Koelblinger, Barbara Seliger
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients. Oncoimmunology 9 (1) (2020)
Michael Friedrich, Christine Stoehr, Simon Jasinski-Bergner, Arndt Hartmann, Sven Wach, Bernd Wullich, André Steven, Barbara Seliger
Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma. Journal of translational medicine 18 (1) (2020)
André Steven, Chiara Massa, Barbara Seliger
"Tumor immunology meets oncology (TIMO) XV", April 25th-27th 2019, Halle/Saale, Germany. Cancer immunology, immunotherapy : CII 69 (5) (2020)
Michael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, Karthikeyan Subbarayan, Chiara Massa, Sandy Tretbar, Anja Mueller, Diana Handke, Katharina Biehl, Jürgen Bukur, Marco Donia, Ofer Mandelboim, Barbara Seliger
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer immunology, immunotherapy : CII 68 (10) (2019)
André Steven, Barbara Seliger
"Tumor Immunology Meets Oncology (TIMO) XIV", May 24-26th 2018, Halle/Saale, Germany. Cancer immunology, immunotherapy : CII 68 (10) (2019)
Claudia Lennicke, Jette Rahn, Jürgen Bukur, Falko Hochgräfe, Ludger A Wessjohann, Rudolf Lichtenfels, Barbara Seliger
Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid. Oncoimmunology 6 (6) (2016)

Barbara Seliger.css-eqlu8i{font-size:small;padding-left:4px;} (Chiara Massa)

Publication Activity (10 Years)

Top Topics

Top Venues

Barbara Seliger (Chiara Massa)